Promore Pharma AB elects Marianne Dicander Alexandersson as New Board Member and outlines plans for IPO
STOCKHOLM, SWEDEN, April 26, 2017 – Promore Pharma AB, a Swedish biopharmaceutical developer of therapeutic peptides, today announced the election of Marianne Dicander Alexandersson as new owner-independent board member, part of preparations as the company plans to extend an initial public offering later in 2017.At Promore Pharma’s Annual General Meeting on April 25, 2017, all current board members - Göran Pettersson (Chairman), Torsten Goesch, Satyendra Kumar, and Göran Linder - were re-elected. The board was expanded by the AGM’s election of Marianne Dicander Alexandersson as a new,